| Name | Title | Contact Details |
|---|
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Service and value set Medical Mutual and its Family of Companies apart. A trusted insurer for 80 years, we are the oldest and largest health insurance company headquartered in the state of Ohio. As a mutual company, we operate for the benefit of our members without needing to meet the demands of stockholders or Wall Street analysts. Instead, we focus on developing products and services that allow us to better serve our customers and the communities around us and help our members achieve their best possible health and quality of life. The work you do and the team you choose has a huge impact on your life. If you are seeking a challenging and supportive work environment that will help you be your best, then you belong with an organization that values high performance and ambition — Medical Mutual. Our reputation of great service is the result of an exceptional team effort from our dedicated employees. We offer an attractive compensation package that includes excellent benefits, a 401K plan with a company match, an on-site fitness center, employee wellness programs, professional development and much more. Discover Medical Mutual and all we have to offer.
Wolters Kluwer Clinical Drug Information connects you to the information and technology you need to strengthen medication decision making.
inVentiv Health, Inc. provides value-added services to the pharmaceutical, life sciences, and healthcare industries. The Company operates in four segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. The Company supports a range of clinical development, communications and commercialization activities that are critical to its customers' ability to complete the development of drug products and medical devices and commercialize them. In addition, the Company provides medical cost containment services to payors in its patient outcomes business. inVentiv provides services to over 350 client organizations, including global pharmaceutical companies, emerging and specialty biotechnology companies, and payors.
Priority Dispatch Corporation is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.